Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;59(6):1670-6.
doi: 10.1016/j.jvs.2013.05.033. Epub 2013 Jul 19.

Diet-induced obesity drives negative mouse vein graft wall remodeling

Affiliations

Diet-induced obesity drives negative mouse vein graft wall remodeling

Peng Yu et al. J Vasc Surg. 2014 Jun.

Abstract

Introduction: The heightened inflammatory phenotype associated with obesity has been linked to the development of cardiovascular diseases. Short-term high-fat feeding induces a proinflammatory state that may impact the blood vessel wall. CD11c, a significantly increased dendritic cell biomarker during diet-induced obesity (DIO), may have a mechanistic role in this high-fat feeding effect. We hypothesized that the proinflammatory effect of short-term DIO accelerates vein bypass graft failure via CD11c-dependent mechanisms.

Methods: Male 9-week-old DIO mice (n = 13, C57BL/6J recipients; n = 6, CD11c(-/-) recipients) and normal chow controls (n = 15, C57BL/6J recipients; n = 6, CD11c(-/-) recipients) underwent unilateral carotid interposition vein isografting (inferior vena cava from the same diet and genetic background donor), with a midgraft or outflow focal stenosis. Vein grafts were harvested at either 1 week (immunohistochemical staining for early CD11c expression) or 4 weeks later (morphometric analyses and CD11c evaluation).

Results: Despite a 40% larger body size, C57BL/6J DIO mice had 44% smaller poststenosis vein graft lumens (P = .03) than their controls via an acceleration of overall negative vein graft wall remodeling in the day-28 midgraft focal stenosis model but not in the outflow stenosis model. Higher CD11c expression occurred in DIO midgraft-stenosis vein graft walls, both at postoperative days 7 and 28. In contrast, with in vivo CD11c deficiency, DIO did not elicit this poststenotic negative remodeling but attenuated intimal hyperplasia.

Conclusions: These findings highlight negative wall remodeling as a potential factor leading to vein graft failure and provide direct evidence that short-term dietary alterations in the mammalian metabolic milieu can have lasting implications related to acute vascular interventions. DIO induces negative mouse vein graft wall remodeling via CD11c-depedent pathways.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Weight curves of vein grafted mice (C57BL/6J or CD11c−/−), with 60 kcal% high-fat diet (DIO) or 10 kcal% standard chow (Normal). Values are shown as mean ± SEM.
Fig 2
Fig 2
Serial crosssectional analysis of vein graft (midgraft portion) wall adaptation in C57BL/6J (AE) and CD11c−/− (FJ), normal chow vs. DIO mouse midgraft focal stenosis model. A,F: Mean calculated lumen area. B,G: Mean IEL perimeter. C,H: Mean intima thickness. D,I: Mean media+adventitia thickness. E,J: Mean intima/(media+adventitia) thickness ratio. Values were shown as means ± SEM. * P<.05 and ** P<.01 vs. the same location of vein graft in normal chow counterpart mice. K–N: Representative Masson’s trichrome stained images at 400 μm distal to midgraft focal stenosis (D400). K: C57 Normal; L: C57 DIO; M: CD11c−/− Normal; N: CD11c−/− DIO. Three hand-drawn black lines in each image delineate the boundaries of different layers of vein graft wall. From the lumen to the outside: lumen boundary, internal elastic lamina, and outside boundary. Scale bar = 200 μm.
Fig 3
Fig 3
Morphologic analysis of vein graft wall adaptation with outflow focal stenosis, in C57BL/6J normal chow vs. DIO mice. A, Mean calculated lumen area. B, Mean IEL perimeter. C: Mean intima thickness. D, Mean media+adventitia thickness. E, Mean intima/(media+adventitia) thickness ratio. Values were shown as means ± SEM.
Fig 4
Fig 4
The representative CD11c immunohistochemical images and the quantitative analysis of midgraft stenotic vein graft wall in C57BL/6J normal chow vs. DIO mice. Day-7 vein grafts were acetone fixed and cryosectioned; day-28 grafts were formalin fixed and citrate buffer prepared. Note the brown membrane labeling of irregular-shaped cells mainly in the adventitial or adjacent soft tissue of vein graft wall. Scale bars = 50 μm. * P<.05 vs. C57 normal chow mice at the same time point.

Similar articles

Cited by

References

    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245. - PMC - PubMed
    1. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Jr, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–54. - PubMed
    1. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–51. discussion 51. - PubMed
    1. Zhang L, Peppel K, Brian L, Chien L, Freedman NJ. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol. 2004;24:2277–83. - PubMed
    1. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC, et al. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am J Physiol Heart Circ Physiol. 2006;290:H1651–H9. - PubMed

Publication types